A Phase 1 Open Label, Dose Escalation Study of Nilotinib in Steroid Dependent/Refractory Chronic Graft-Versus-Host Disease 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Chen, G. L., Carpenter, P. A., Broady, R., Gregory, T. B., Arai, S., Johnston, L., Flowers, M. E., Beumer, J. H., Mendolsohn, J., Zhou, X., Perloff, S. H., Otani, J. M., Miklos, D. B. AMER SOC HEMATOLOGY. 2011: 866–67

View details for Web of Science ID 000299597102581